[1]
B. R. Rani, M. A. Kumar, K. S. Babu, and T. N. Rao, “An open label randomized placebo-controlled study of apremilast in common immune mediated papulosquamous hair and pigmentary dermatoses”, Int J Res Dermatol, vol. 8, no. 2, pp. 254–259, Feb. 2022.